BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND H3F3A, P84243, H3_3B, MGC87783, MGC87782, H3F3, H3_3A, ENSG00000163041, 3020
9 results:

  • 1. Adult granulosa cell tumor of the testis with malignant tendency: A case report with genetic analysis using high-throughput sequencing.
    Deng L; Zeng J; Qiu JF; Yang LH; Ma J
    Medicine (Baltimore); 2023 Aug; 102(32):e34523. PubMed ID: 37565864
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed ovarian cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45).
    Monk BJ; Parkinson C; Lim MC; O'Malley DM; Oaknin A; Wilson MK; Coleman RL; Lorusso D; Bessette P; Ghamande S; Christopoulou A; Provencher D; Prendergast E; Demirkiran F; Mikheeva O; Yeku O; Chudecka-Glaz A; Schenker M; Littell RD; Safra T; Chou HH; Morgan MA; Drochýtek V; Barlin JN; Van Gorp T; Ueland F; Lindahl G; Anderson C; Collins DC; Moore K; Marme F; Westin SN; McNeish IA; Shih D; Lin KK; Goble S; Hume S; Fujiwara K; Kristeleit RS
    J Clin Oncol; 2022 Dec; 40(34):3952-3964. PubMed ID: 35658487
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.
    Escala-Garcia M; Canisius S; Keeman R; Beesley J; Anton-Culver H; Arndt V; Augustinsson A; Becher H; Beckmann MW; Behrens S; Bermisheva M; Bojesen SE; Bolla MK; Brenner H; Canzian F; Castelao JE; Chang-Claude J; Chanock SJ; Couch FJ; Czene K; Daly MB; Dennis J; Devilee P; Dörk T; Dunning AM; Easton DF; Ekici AB; Eliassen AH; Fasching PA; Flyger H; Gago-Dominguez M; García-Closas M; García-Sáenz JA; Geisler J; Giles GG; Grip M; Gündert M; Hahnen E; Haiman CA; Håkansson N; Hall P; Hamann U; Hartikainen JM; Heemskerk-Gerritsen BAM; Hollestelle A; Hoppe R; Hopper JL; Hunter DJ; Jacot W; Jakubowska A; John EM; Jung AY; Kaaks R; Khusnutdinova E; Koppert LB; Kraft P; Kristensen VN; Kurian AW; Lambrechts D; Le Marchand L; Lindblom A; Luben RN; Lubiński J; Mannermaa A; Manoochehri M; Margolin S; Mavroudis D; Muranen TA; Nevanlinna H; Olshan AF; Olsson H; Park-Simon TW; Patel AV; Peterlongo P; Pharoah PDP; Punie K; Radice P; Rennert G; Rennert HS; Romero A; Roylance R; Rüdiger T; Ruebner M; Saloustros E; Sawyer EJ; Schmutzler RK; Schoemaker MJ; Scott C; Southey MC; Surowy H; Swerdlow AJ; Tamimi RM; Teras LR; Thomas E; Tomlinson I; Troester MA; Vachon CM; Wang Q; Winqvist R; Wolk A; Ziogas A; ; Michailidou K; Chenevix-Trench G; Bachelot T; Schmidt MK
    Sci Rep; 2021 Oct; 11(1):19787. PubMed ID: 34611289
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA-MONO) and rucaparib in combination with nivolumab (ATHENA-COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer.
    Monk BJ; Coleman RL; Fujiwara K; Wilson MK; Oza AM; Oaknin A; O'Malley DM; Lorusso D; Westin SN; Safra T; Herzog TJ; Marmé F; N Eskander R; Lin KK; Shih D; Goble S; Grechko N; Hume S; Maloney L; McNeish IA; Kristeleit RS
    Int J Gynecol Cancer; 2021 Dec; 31(12):1589-1594. PubMed ID: 34593565
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Abemaciclib plus fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in premenopausal women: subgroup analysis from the MONARCH 2 trial.
    Neven P; Rugo HS; Tolaney SM; Iwata H; Toi M; Goetz MP; Kaufman PA; Lu Y; Haddad N; Hurt KC; Sledge GW
    Breast Cancer Res; 2021 Aug; 23(1):87. PubMed ID: 34425869
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2-Year Durable Response.
    Valiakhmetova A; Gorelyshev S; Konovalov A; Trunin Y; Savateev A; Kram DE; Severson E; Hemmerich A; Edgerly C; Duncan D; Britt N; Huang RSP; Elvin J; Miller V; Ross JS; Gay L; McCorkle J; Rankin A; Erlich RL; Chudnovsky Y; Ramkissoon SH
    Oncologist; 2020 Feb; 25(2):e198-e202. PubMed ID: 32043779
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues.
    Romani C; Calza S; Todeschini P; Tassi RA; Zanotti L; Bandiera E; Sartori E; Pecorelli S; Ravaggi A; Santin AD; Bignotti E
    PLoS One; 2014; 9(12):e113781. PubMed ID: 25473950
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Are serum HE4 or ROMA scores useful to experienced examiners for improving characterization of adnexal masses after transvaginal ultrasonography?
    Kaijser J; Van Gorp T; Smet ME; Van Holsbeke C; Sayasneh A; Epstein E; Bourne T; Vergote I; Van Calster B; Timmerman D
    Ultrasound Obstet Gynecol; 2014 Jan; 43(1):89-97. PubMed ID: 23828371
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The human plasma proteome: analysis of Chinese serum using shotgun strategy.
    He P; He HZ; Dai J; Wang Y; Sheng QH; Zhou LP; Zhang ZS; Sun YL; Liu F; Wang K; Zhang JS; Wang HX; Song ZM; Zhang HR; Zeng R; Zhao X
    Proteomics; 2005 Aug; 5(13):3442-53. PubMed ID: 16047309
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.